| Primary |
| Product Used For Unknown Indication |
40.2% |
| Diagnostic Procedure |
26.9% |
| Therapeutic Procedure |
7.5% |
| Drug Use For Unknown Indication |
7.2% |
| Thyroid Cancer |
3.5% |
| Scan Thyroid Gland |
1.9% |
| Hypertension |
1.6% |
| Goitre |
1.4% |
| Whole Body Scan |
1.4% |
| Contraception |
1.2% |
| Hypothyroidism |
1.2% |
| Depression |
0.9% |
| Supplementation Therapy |
0.9% |
| Hormone Replacement Therapy |
0.7% |
| Hyperlipidaemia |
0.7% |
| Metastasis |
0.7% |
| Premedication |
0.7% |
| Diabetes Mellitus |
0.5% |
| Hormone Suppression Therapy |
0.5% |
| Hyperthyroidism |
0.5% |
|
| Vomiting |
23.5% |
| Hypersensitivity |
7.1% |
| Nausea |
6.1% |
| Presyncope |
6.1% |
| Tremor |
6.1% |
| Abortion Spontaneous |
4.1% |
| Paraesthesia Oral |
4.1% |
| Tachycardia |
4.1% |
| Thrombophlebitis |
4.1% |
| Vision Blurred |
4.1% |
| Acute Myocardial Infarction |
3.1% |
| Blood Thyroid Stimulating Hormone Decreased |
3.1% |
| Cerebrovascular Accident |
3.1% |
| Malaise |
3.1% |
| Muscular Weakness |
3.1% |
| Nephrolithiasis |
3.1% |
| Palpitations |
3.1% |
| Paresis Cranial Nerve |
3.1% |
| Tendon Disorder |
3.1% |
| Thyroid Cancer |
3.1% |
|
| Secondary |
| Therapeutic Procedure |
33.3% |
| Diagnostic Procedure |
25.0% |
| Product Used For Unknown Indication |
25.0% |
| Thyroid Cancer |
16.7% |
|
| Nephrolithiasis |
37.5% |
| White Blood Cell Count Decreased |
25.0% |
| Inappropriate Schedule Of Drug Administration |
12.5% |
| Pharyngeal Oedema |
12.5% |
| Presyncope |
12.5% |
|
| Concomitant |
| Goitre |
58.3% |
| Cough |
8.3% |
| Premedication |
8.3% |
| Anxiety |
4.2% |
| Depression |
4.2% |
| Hypothyroidism |
4.2% |
| Insomnia |
4.2% |
| Otorrhoea |
4.2% |
| Product Used For Unknown Indication |
4.2% |
|
| Hypothyroidism |
63.6% |
| Blindness Transient |
9.1% |
| Blood Thyroid Stimulating Hormone Decreased |
9.1% |
| Hypersensitivity |
9.1% |
| Pain |
9.1% |
|
